A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT07759245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, 52-week Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.
Study identification
- NCT ID
- NCT07759245
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 606 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2026
- Primary completion
- Apr 30, 2028
- Completion
- Oct 31, 2028
- Last update posted
- Aug 23, 2026
2026 – 2028
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| NewportNativeMD, Inc. | Newport Beach | California | 92663 | — |
| Institute of HealthCare Assessment d/b/a Apex Clinical Research | San Diego | California | 92120 | — |
| National Jewish Health Medical Center | Denver | Colorado | 80206 | — |
| Millennium Medical Research - Miami | Miami | Florida | 33126 | — |
| Deluxe Health Center | Miami Lakes | Florida | 33014 | — |
| Florida Institute For Clinical Research, LLC | Orlando | Florida | 32825 | — |
| Axis Clinical Trials - Westchester | Westchester | Illinois | 60154 | — |
| Indiana University Health University Hospital | Indianapolis | Indiana | 46202 | — |
| IU Health Ball Memorial Hospital, Inc. | Muncie | Indiana | 47303 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Revive Research Institute, Inc. | Southfield | Michigan | 48075 | — |
| Headlands Research-Twin Cities | Maplewood | Minnesota | 55109 | — |
| Clinical Research Associates of Central PA | DuBois | Pennsylvania | 15801 | — |
| Premier Pulmonary Critical Care and Sleep | Denison | Texas | 75020 | — |
| Baylor College of Medicine Medical Center | Houston | Texas | 77030 | — |
| Prime Clinical Research - Lewisville | Lewisville | Texas | 75067 | — |
| Paramount Clinical Research - Data Point Clinical Research | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 110 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07759245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07759245 live on ClinicalTrials.gov.